$0.165
-0.004 (-2.20%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de TOVX por análisis de gráficos similares
Alphio's TOVX stock price prediction model matches the current Theriva Biologics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.17 (+0.25%). The 1-week path is $0.16 (-0.76%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Theriva Biologics Inc?
Given the current price of $0.16 and an RSI of 29.724, indicating oversold conditions, it may seem tempting to buy. However, the stock has a troubling 1-year change of -43.40% and a forward P/E ratio of 0, suggesting no earnings growth is expected. The main risk is the company's recent financial performance, with a net loss of $2.04 million reported for Q1 2026, which is an improvement but still concerning. Therefore, it is advisable to sell rather than buy at this time.
TOVX cerró en $0.16 el Friday, tras bajar -2.20%
Theriva Biologics Inc (TOVX) last closed at $0.1647, losing -2.20%. These facts feed the 1-day and 1-week TOVX price prediction above.
Factores de la previsión
Los factores de la previsión de Theriva Biologics Inc (TOVX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de TOVX, ordenadas por similitud.
Análisis de estacionalidad de TOVX
Historically the probability of a positive November return for TOVX is 0.00%. February offers the highest probability of a positive month at 37.93%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de TOVX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.34 | $0.43 | $0.48 | +161.74% |
| Dec 2026 | $0.58 | $0.58 | $0.66 | +254.11% |
En 2026, se proyecta que Theriva Biologics Inc (TOVX) oscile entre $0.34 y $0.66.
Previsión mensual de Theriva Biologics Inc para 2026
En Nov de 2026, se proyecta que Theriva Biologics Inc promedie $0.43, con un mínimo de $0.34 y un máximo de $0.48.
En Dec de 2026, se proyecta que Theriva Biologics Inc promedie $0.58, con un mínimo de $0.58 y un máximo de $0.66.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.